Molecular mechanisms underlying the development of neuroendocrine prostate cancer.

Liu, Shiqin; Alabi, Busola Ruth; Yin, Qingqing; Stoyanova, Tanya

Liu, Shiqin; Alabi, Busola Ruth; Yin, Qingqing; Stoyanova, Tanya.

Afiliação

Liu S; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Palo Alto, CA, USA.
Alabi BR; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Palo Alto, CA, USA.
Yin Q; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Palo Alto, CA, USA.
Stoyanova T; Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, Palo Alto, CA, USA. Electronic address: stanya@stanford.edu.

Semin Cancer Biol ; 86(Pt 3): 57-68, 2022 11.

Article em En | MEDLINE | ID: mdl-35597438

Assuntos

Carcinoma Neuroendócrino; Neoplasias da Próstata; Masculino; Humanos; Neoplasias da Próstata/genética; Neoplasias da Próstata/terapia; Antagonistas de Androgênios/uso terapêutico; Carcinoma Neuroendócrino/genética

Palavras-chave

Molecular mechanism; Neuroendocrine differentiation; Neuroendocrine prostate cancer; Therapeutic targets

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Carcinoma Neuroendócrino Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google